• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Octaneuropeptide

Octaneuropeptide

Product ID O0978
Cas No.
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $189.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Octaneuropeptide exhibits anorexigenic activity and may also display epileptogenic potential. Octaneuropeptide is a C-terminal fragment of octadecaneuropeptide, a derivative of diazepam-binding inhibitor (DBI). Octaneuropeptide increases intracellular Ca2+ levels in astrocytes in a PLC-dependent manner.

Product Info

Purity

≥98%

Formula

C41H74N12O11

Formula Wt.

911.1

Solubility

Soluble in water.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

O0978 MSDS PDF

Info Sheet

O0978 Info Sheet PDF

References

Leprince J, Oulyadi H, Vaudry D, et al. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur J Biochem. 2001 Dec;268(23):6045-57. PMID: 11732998.

Vezzani A, Serafini R, Stasi MA, et al. Epileptogenic activity of two peptides derived from diazepam binding inhibitor after intrahippocampal injection in rats. Epilepsia. 1991 Sep-Oct;32(5):597-603. PMID: 1655399.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P2522

    S-(N-Phenylthiocarbamoyl)-glutathione

    Glutathione-ITC conjugate, antioxidant.
    ≥98%
  • AS113

    Evodia Standards Kit

    Evodia Standards Kit Contents: -Column: Cosmosil 2...
  • C2943

    Chlorogenic Acid (from Eucommia)

    Polyphenol derivative of caffeic acid found in Euc...
    ≥98%
  • K1678

    Ketanserin

    5-HT2A antagonist, potential α1-adrenergic antago...
    ≥97%
  • K0030

    Kahweol

    Diterpene found in coffee beans.
    ≥97%
  • V0045

    Valacyclovir Hydrochloride

    Neuraminidase inhibitor.
    ≥98%
  • R2599

    RGYSLG

    Peptide, represents generic protein kinase active ...
    ≥95%
  • K9200

    KX1-004

    Indole; Src inhibitor.
    ≥98%
  • N1981

    Neuromedin C (18-27), pig

    Endogenous bombesin-related peptide, involved in e...
    ≥98%
  • R1775

    Resiniferonol-9,13,14-orthophenyl Acetate

    Diterpene vanilloid derivative of resiniferatoxin;...
    ≥98%
  • P6802

    Pranoprofen

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • R162041

    Rebaudioside A

    Steviol glycoside used as sucrose substitute
    ≥98%
  • E537331

    Enniatin Complex

    Mycotoxin contaminant found in cereal grains.
    ≥98%
  • T3093

    Thymopentin

    Synthetic peptide, thymopoietin analog.
    ≥95%
  • A1318

    Adenine

    Endogenous purine nucleotide base, required for sy...
    ≥98%
  • M1875

    S-(N-Methylsulfinylbutylthiocarbamoyl)-glutathione

    Glutathione-sulforaphane conjugate, antioxidant.
    ≥98%
  • D5692

    Doxifluridine

    5-Fluorouracil prodrug, pyrimidine nucleoside anal...
    ≥98%
  • I0801

    IC261

    Casein kinase 1 inhibitor.
    ≥98%
  • C1176

    CCT-128930

    Pyrrolopyrimidine; Akt inhibitor.
    ≥98%
  • B1992

    Bexarotene

    RXR agonist.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only